A heavily researched, well written article in Bloomberg Businessweek published this week, sheds light on the efforts of the NIH and FBI to target ethnic Chinese scientists, including U.S. citizens, searching for a cancer cure. The article provides the first in-depth account of what happened to Xifeng Wu, former Director of the Center for Public Health and Translational Genomics at the University of Texas MD Anderson Cancer Center in Houston. There is even a term that has been coined to refer to cancer researchers identified by the NIH as possibly having too close of ties to China, “oncological double agent”. Learn More